v3.22.2.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues
Operating expenses:        
Research and development 1,037,111 1,634,063 3,730,319 6,906,510
General and administrative 1,433,699 1,777,000 4,735,402 5,720,043
Total operating expenses 2,470,810 3,411,063 8,465,721 12,626,553
Operating loss (2,470,810) (3,411,063) (8,465,721) (12,626,553)
Other income (expense):        
Interest income 78,902 1,226 97,274 4,366
Interest expense (7,562) (1,479) (32,547)
Amortization of debt discount and offering costs (4,359) (8,723) (28,733)
Total other income (expense) 78,902 (10,695) 87,072 (56,914)
Net loss $ (2,391,908) $ (3,421,758) $ (8,378,649) $ (12,683,467)
Basic and diluted net loss per share (in Dollars per share) $ (0.82) $ (1.61) $ (2.9) $ (6.09)
Weighted average common shares outstanding - basic and diluted (in Shares) 2,903,403 2,129,686 2,890,723 2,081,318

Source